ENGLISH| 亚搏手机版网页登陆| 书记院长信箱|
当前位置: 首页 >> 教师简介 >> 正文


黄 赞/Huang, Zan
时间:2016-12-26 09:42:11 阅读量:

职称职务:博士、教授/PhD, Professor
学科专业:生物化学与分子生物学/Biochemistry and Molecular Biology
科研方向:造血与白血病、肝脏代谢病变/Hematopoiesis and leukemia; Liver Metabolism-associated Diseases
Email: z-huangATwhu.edu.cn


1990/09-1994/07,亚搏手机版网页登陆  学士/ Wuhan  University  Bachelor
1994/09-1998/07,亚搏手机版网页登陆  硕士/Wuhan  University  Master
2001/08-2006/05,芝加哥洛约拉大学 博士/Loyola  University Chicago, PhD
2006/01-2006/12,美国芝加哥大学肿瘤研究所  博士后/ University of Chicago Ben May Institute for Cancer Research  Post-doctoral Fellow
2007/01-2010/02,美国西北大学医学院  博士后/Northwestern University Feinberg School of Medicine  Post-doctoral

工作经历/Professional experience:
1998/08-2001/01 上海市儿童医院  研究助理/Children’s Hospital of Shanghai   Research Associate
2001 Loyola University Chicago 研究助理/Research Associate
2010/03-至今:亚搏手机版网页登陆  教授/ Wuhan University College of Life Sciences

社会兼职/Professional Affiliation:
美国血液学学会/American Society of Hematology
亚太生物医学免疫学学会常务理事/Executive Director of Asia-Pacific Association of Medicine and Bio-Immunology
中国细胞生物学学会/Chinese Society for Cell Biology
中国生理学学会/Chinese Association for Physiological Sciences

Research interests:
 Our laboratory is dedicated to explore the molecular basis of hematopoiesis, hematopoietic malignancies and liver metabolism-associated diseases. Major researches include:
1. Megakaryopoiesis and pathogenesis of Myeloproliferative Neoplasms (MPNs) and Acute Myeloid Leukemia (AML): We investigate signal transduction, transcriptional, and epigenetic regulation of megakaryopoiesis; explore the molecular basis of MPNs (Primary Myelofibrosis) for target therapy; identify key regulators controlling AML cell proliferation, survival, and malignancy as well as novel biomarkers.
2. Pathogenesis of liver metabolism-associated diseases: We dissect molecular mechanism underlying the progressive evolution of Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH), Cirrhosis to Hepatocellular Carcinoma; unveil the decisive factors determining Hepatic Ischemia/Reperfusion Injury; particularly focus the function of innate immunity and ubiquitination/deubiquitination that regulate metabolism and ultimately contributes to these diseases .

教学课程/Course director:
1、生物化学 (本科)Biochemistry for undergraduates
2、造血细胞发育与分化(研究生)Hematopoiesis for graduates

1.自然科学青年基金(2008-2010)/Natural Science Foundation Committee
2.自然科学基金面上项目(2011-2013)/Natural Science Foundation Committee
3.自然科学基金面上项目(2014-2017)/Natural Science Foundation Committee
4.自然科学基金面上项目(2017-2020)/Natural Science Foundation Committee
5.教育部博士点基金(2012-2014)/Ph.D. Programs Foundation
6.教育部“新世纪优秀人才支持计划”(2013-2015)/New Century Excellent Talents in

代表性论文/Selected Publications:
1. Yang X, Lu B, Sun X, Han C, Fu C, Xu K, Wang M, Li D, Chen Z, Opal P, Wen Q, Crispino JD, Wang QF# & Huang Z#. ANP32A regulates histone H3 acetylation and promotes leukemogenesis. Leukemia. 2018;doi:10.1038/s41375-018-0010-7.

2. Ji YX*, Huang Z*, Yang X*, Wang X*, Zhao LP, Wang PX, Zhang XJ, Alves-Bezerra M, Cai L, Zhang P, Lu YX, Bai L, Gao MM, Zhao H, Tian S, Wang Y, Huang ZX, Zhu XY, Zhang Y, Gong J, She ZG, Li F, Cohen DE & Li H. The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis. Nat Med. 2018.

3. Yan FJ, Zhang XJ, Wang WX, Ji YX, Wang PX, Yang Y, Gong J, Shen LJ, Zhu XY, Huang Z# & Li H#. The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis. Hepatology. 2017;65(5):1492-1511.

4. Wang X, Mao W, Fang C, Tian S, Zhu X, Yang L, Huang Z# & Li H#. Dusp14 protects against hepatic ischaemia-reperfusion injury via Tak1 suppression. J Hepatol. 2017.

5. Lu B, Ren Y, Sun X, Han C, Wang H, Chen Y, Peng Q, Cheng Y, Cheng X, Zhu Q, Li W, Li HL, Du HN, Zhong B#, Huang Z#. Induction of INKIT by Viral Infection Negatively Regulates Antiviral Responses through Inhibiting Phosphorylation of p65 and IRF3. Cell Host Microbe. 2017;22(1):86-98 e84.

6. Yan FJ, Zhang XJ, Wang WX, Ji YX, Wang PX, Yang Y, Gong J, Shen LJ, Zhu XY, Huang Z#, Li H#. The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis. Hepatology. 2017;65(5):1492-1511.

7. Wang PX, Ji YX, Zhang XJ, Zhao LP, Yan ZZ, Zhang P, Shen LJ, Yang X, Fang J, Tian S, Zhu XY, Gong J, Zhang X, Wei QF, Wang Y, Li J, Wan L, Xie Q, She ZG, Wang Z, Huang Z, Li H. Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates. Nat Med. 2017;23(4):439-449.

8. Jin Q, Ren Y, Wang M, Suraneni PK, Li D, Crispino JD, Fan J#, Huang Z#. Novel function of FAXDC2 in megakaryopoiesis. Blood Cancer J. 2016;6(9):e478.

9. Lu B, Sun X, Chen Y, Jin Q, Liang Q, Liu S, Li Y, Zhou Y, Li W, Huang Z#. Novel function of PITH domain-containing 1 as an activator of internal ribosomal entry site to enhance RUNX1 expression and promote megakaryocyte differentiation. Cellular and Molecular Life Sciences: CMLS. 2015. 72(4): 821-832

10. Lin Y, Li D, Liang Q, Liu S, Zuo X, Li L, Sun X, Li W, Guo M, Huang Z#. miR-638 Regulates Differentiation and Proliferation in Leukemic Cells by Targeting Cyclin-dependent Kinase 2.  J Biol Chem. 2015. 290(3): 1818-1828

11. Sun X, Lu B, Hu B, Xiao W, Li W, Huang Z#. Novel function of the chromosome 7 open reading frame 41 gene to promote leukemic megakaryocyte differentiation by modulating TPA-induced signaling. Blood Cancer J.2014. 4: e198

12. Liu L, Wen Q, Gong R, Gilles L, Stankiewicz MJ, Li W, Guo M, Li L, Sun X, Crispino JD, Huang Z#. PSTPIP2 dysregulation contributes to aberrant terminal differentiation in GATA-1-deficient megakaryocytes by activating LYN. Cell Death & Disease. 2014. 5: e988

13. Wang W, Cai J, Wu Y, Hu L, Chen Z, Hu J, Li W, Guo M, Huang Z#. Novel activity of KRAB domain that functions to reinforce nuclear localization of KRAB-containing zinc finger proteins by interacting with KAP1. Cellular and Molecular Life Sciences: CMLS.2013. 70(20): 3947-3958

14. Khan I*, Huang Z*, Wen Q, Stankiewicz MJ, Gilles L, Goldenson B, Schultz R, Diebold L, Gurbuxani S, Finke CM, Lasho TL, Koppikar P, Pardanani A, Stein B, Altman JK, Levine RL, Tefferi A, Crispino JD. AKT is a therapeutic target in myeloproliferative neoplasms. Leukemia.2013. 27(9): 1882-1890

15. Wen Q, Goldenson B, Silver SJ, Schenone M, Dancik V, Huang Z, Wang LZ, Lewis TA, An WF, Li X, Bray MA, Thiollier C, Diebold L, Gilles L, Vokes MS, Moore CB, Bliss-Moreau M, Verplank L, Tolliday NJ, Mishra R, Vemula S, Shi J, Wei L, Kapur R, Lopez CK, Gerby B, Ballerini P, Pflumio F, Gilliland DG, Goldberg L, Birger Y, Izraeli S, Gamis AS, Smith FO, Woods WG, Taub J, Scherer CA, Bradner JE, Goh BC, Mercher T, Carpenter AE, Gould RJ, Clemons PA, Carr SA, Root DE, Schreiber SL, Stern AM, Crispino JD. Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL. Cell.2012. 150(3): 575-589

16. Wang W, Guo M, Hu L, Cai J, Zeng Y, Luo J, Shu Z, Li W#, Huang Z#. The zinc finger protein ZNF268 is overexpressed in human cervical cancer and contributes to tumorigenesis via enhancing NF-kappaB signaling. J Biol Chem.2012. 287(51): 42856-42866

17. Huang Z, Dore LC, Li Z, Orkin SH, Feng G, Lin S, Crispino JD. GATA-2 reinforces megakaryocyte development in the absence of GATA-1. Mol Cell Biol. 2009;29(18):5168-5180.

18. Huang Z, Richmond TD, Muntean AG, Barber DL, Weiss MJ, Crispino JD. STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice. J Clin Invest. 2007;117(12):3890-

John D. Crispino,Qiang Wen,Zan Huang,Andrew M. Robert J. Stern,Dimethyl fasudil for inducing polyploidization of megakaryocytes and for treating blood and bone marrow diseases and disorders,Issue Date: January 13, 2015, United States,8933071。